Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors
JAMA oncology | 15 Apr 2016
YE Nikiforov, RR Seethala, G Tallini, ZW Baloch, F Basolo, LD Thompson, JA Barletta, BM Wenig, A Al Ghuzlan, K Kakudo, TJ Giordano, VA Alves, E Khanafshar, SL Asa, AK El-Naggar, WE Gooding, SP Hodak, RV Lloyd, G Maytal, O Mete, MN Nikiforova, V Nosé, M Papotti, DN Poller, PM Sadow, AS Tischler, RM Tuttle, KB Wall, VA LiVolsi, GW Randolph and RA Ghossein
Although growing evidence points to highly indolent behavior of encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC), most patients with EFVPTC are treated as having conventional thyroid cancer.
* Data courtesy of Altmetric.com